The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-Small Cell Lung Cancer

Clinical Oncology - United Kingdom
doi 10.1016/j.clon.2016.08.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Novel Drug-Resistance Mechanisms of Pemetrexed-Treated Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

Amplifying Outcomes: Checkpoint Inhibitor Combinations in First‐Line Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Tackling ALK in Non-Small Cell Lung Cancer: The Role of Novel Inhibitors

Translational Lung Cancer Research
Oncology
2016English

Targeting Glutamine Metabolism to Improve Radiation Sensitivity in Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

A Novel Paradigm in the Treatment of Oligometastatic Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2008English

Clinical Challenges in Targeting Anaplastic Lymphoma Kinase in Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Frontiers in Oncology
Cancer ResearchOncology
2018English

Non-Small Cell Lung Cancer

English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy